Skip to main content
Top
Published in: Dermatology and Therapy 6/2021

Open Access 01-12-2021 | Erythema | Original Research

Clinical Features and Risk Factors for Nasal Rosacea: A Hospital-Based Retrospective Study

Authors: Ai-ke Wu, Fang-fen Liu, Hong-fu Xie, Zhi-xiang Zhao, Yan Tang, Ying-xue Huang, Dan Jian, Wei Shi, Ben Wang, Ji Li

Published in: Dermatology and Therapy | Issue 6/2021

Login to get access

Abstract

Introduction

At present, some studies have reported that nasal rosacea may be an independent disease, but phenotypic characteristics and risk factors for nasal rosacea remain unknown. This study aimed to clarify the clinical features and explore the risk factors for nasal rosacea.

Methods

A hospital-based retrospective study was conducted, including 1615 rosacea patients and 1501 healthy individuals. The patients were divided into three groups based on the involved areas of the lesions (non-nasal, intermediate and nasal rosacea group). Their demographic data and clinical features were obtained from patients’ medical records, and risk factors of nasal rosacea were analyzed.

Results

There were 927 (57.4%), 647 (40.1%) and 41 (2.5%) cases in the non-nasal, intermediate and nasal rosacea groups, respectively. Of 41 patients with nasal rosacea, all (100.0%) had fixed erythema and 17 cases (41.5%) had phymatous changes. Compared with control group, male gender (adjusted odds ratio [aOR] = 2.39, 95% confidence interval [CI] = 1.14, 4.99), obesity (aOR = 3.19, 95% CI 1.86, 11.79) and alcohol use (aOR = 1.58, 95% CI 1.22, 5.40) were risk factors for nasal rosacea, but these three factors were not risk factors for non-nasal rosacea and intermediate rosacea groups. Among patients with nasal lesions (compared with patients without nasal phymatous changes), family history of rosacea was a risk factor (aOR = 2.12, 95% CI 1.01, 4.46) for nasal phymatous changes and Fitzpatrick IV skin type was a protective factor (aOR = 0.49, 95% CI 0.28, 0.86).

Conclusion

Nasal rosacea has relatively specific clinical features and independent risk factors, suggesting that it may be a special type of rosacea.
Literature
1.
go back to reference Korting HC, Schollmann C. Current topical and systemic approaches to treatment of rosacea. J Eur Acad Dermatol Venereol. 2009;23:876–82.CrossRef Korting HC, Schollmann C. Current topical and systemic approaches to treatment of rosacea. J Eur Acad Dermatol Venereol. 2009;23:876–82.CrossRef
2.
go back to reference Crawford GH, Pelle MT, James WD. Rosacea: I. Etiology, pathogenesis, and subtype classification. J Am Acad Dermatol. 2004;51:327–41 (Quiz 42-4).CrossRef Crawford GH, Pelle MT, James WD. Rosacea: I. Etiology, pathogenesis, and subtype classification. J Am Acad Dermatol. 2004;51:327–41 (Quiz 42-4).CrossRef
3.
go back to reference Gallo RL, Granstein RD, Kang S, et al. Standard classification and pathophysiology of rosacea: the 2017 update by the National Rosacea Society Expert Committee. J Am Acad Dermatol. 2018;78:148–55.CrossRef Gallo RL, Granstein RD, Kang S, et al. Standard classification and pathophysiology of rosacea: the 2017 update by the National Rosacea Society Expert Committee. J Am Acad Dermatol. 2018;78:148–55.CrossRef
4.
go back to reference Schaller M, Almeida LMC, Bewley A, et al. Recommendations for rosacea diagnosis, classification and management: update from the global ROSacea COnsensus 2019 panel. Br J Dermatol. 2020;182:1269–76.CrossRef Schaller M, Almeida LMC, Bewley A, et al. Recommendations for rosacea diagnosis, classification and management: update from the global ROSacea COnsensus 2019 panel. Br J Dermatol. 2020;182:1269–76.CrossRef
5.
go back to reference Tan J, Berg M, Gallo RL, Del Rosso JQ. Applying the phenotype approach for rosacea to practice and research. Br J Dermatol. 2018;179:741–6.CrossRef Tan J, Berg M, Gallo RL, Del Rosso JQ. Applying the phenotype approach for rosacea to practice and research. Br J Dermatol. 2018;179:741–6.CrossRef
6.
go back to reference Tan J, Almeida LM, Bewley A, et al. Updating the diagnosis, classification and assessment of rosacea: recommendations from the global ROSacea COnsensus (ROSCO) panel. Br J Dermatol. 2017;176:431–8.CrossRef Tan J, Almeida LM, Bewley A, et al. Updating the diagnosis, classification and assessment of rosacea: recommendations from the global ROSacea COnsensus (ROSCO) panel. Br J Dermatol. 2017;176:431–8.CrossRef
7.
go back to reference Tan J, Steinhoff M, Berg M, et al. Shortcomings in rosacea diagnosis and classification. Br J Dermatol. 2017;176:197–9.CrossRef Tan J, Steinhoff M, Berg M, et al. Shortcomings in rosacea diagnosis and classification. Br J Dermatol. 2017;176:197–9.CrossRef
8.
go back to reference Abram K, Silm H, Maaroos HI, Oona M. Risk factors associated with rosacea. J Eur Acad Dermatol Venereol. 2010;24:565–71.CrossRef Abram K, Silm H, Maaroos HI, Oona M. Risk factors associated with rosacea. J Eur Acad Dermatol Venereol. 2010;24:565–71.CrossRef
9.
go back to reference Alinia H, Tuchayi SM, Patel NU, et al. Rosacea triggers: alcohol and smoking. Dermatol Clin. 2018;36:123–6.CrossRef Alinia H, Tuchayi SM, Patel NU, et al. Rosacea triggers: alcohol and smoking. Dermatol Clin. 2018;36:123–6.CrossRef
10.
go back to reference Second J, Severac F, Paix A, Cribier B. Rhinophyma is associated with alcohol intake. J Am Acad Dermatol. 2019;81:249–50.CrossRef Second J, Severac F, Paix A, Cribier B. Rhinophyma is associated with alcohol intake. J Am Acad Dermatol. 2019;81:249–50.CrossRef
11.
go back to reference Yuan X, Huang X, Wang B, et al. Relationship between rosacea and dietary factors: a multicenter retrospective case-control survey. J Dermatol. 2019;46:219–25.CrossRef Yuan X, Huang X, Wang B, et al. Relationship between rosacea and dietary factors: a multicenter retrospective case-control survey. J Dermatol. 2019;46:219–25.CrossRef
12.
go back to reference Li S, Cho E, Drucker AM, Qureshi AA, Li WQ. Cigarette smoking and risk of incident Rosacea in women. Am J Epidemiol. 2017;186:38–45.CrossRef Li S, Cho E, Drucker AM, Qureshi AA, Li WQ. Cigarette smoking and risk of incident Rosacea in women. Am J Epidemiol. 2017;186:38–45.CrossRef
13.
go back to reference Li S, Cho E, Drucker AM, Qureshi AA, Li WQ. Obesity and risk for incident rosacea in US women. J Am Acad Dermatol. 2017;77:1083–7.CrossRef Li S, Cho E, Drucker AM, Qureshi AA, Li WQ. Obesity and risk for incident rosacea in US women. J Am Acad Dermatol. 2017;77:1083–7.CrossRef
14.
go back to reference Li S, Chen ML, Drucker AM, et al. Association of caffeine intake and caffeinated coffee consumption with risk of incident rosacea in women. JAMA Dermatol. 2018;154:1394–400.CrossRef Li S, Chen ML, Drucker AM, et al. Association of caffeine intake and caffeinated coffee consumption with risk of incident rosacea in women. JAMA Dermatol. 2018;154:1394–400.CrossRef
15.
go back to reference Tan J, Blume-Peytavi U, Ortonne JP, et al. An observational cross-sectional survey of rosacea: clinical associations and progression between subtypes. Br J Dermatol. 2013;169:555–62.CrossRef Tan J, Blume-Peytavi U, Ortonne JP, et al. An observational cross-sectional survey of rosacea: clinical associations and progression between subtypes. Br J Dermatol. 2013;169:555–62.CrossRef
16.
go back to reference Lee WJ, Jung JM, Won KH, et al. Clinical evaluation of 368 patients with nasal rosacea: subtype classification and grading of nasal rosacea. Dermatology. 2015;230:177–83.CrossRef Lee WJ, Jung JM, Won KH, et al. Clinical evaluation of 368 patients with nasal rosacea: subtype classification and grading of nasal rosacea. Dermatology. 2015;230:177–83.CrossRef
17.
go back to reference Xie HF, Huang YX, He L, et al. An observational descriptive survey of rosacea in the Chinese population: clinical features based on the affected locations. PeerJ. 2017;5: e3527.CrossRef Xie HF, Huang YX, He L, et al. An observational descriptive survey of rosacea in the Chinese population: clinical features based on the affected locations. PeerJ. 2017;5: e3527.CrossRef
18.
go back to reference Lee WJ, Lee YJ, Won CH, Chang SE, Choi JH, Lee MW. Clinical evaluation of 30 patients with localized nasal rosacea. J Dermatol. 2016;43:200–2.CrossRef Lee WJ, Lee YJ, Won CH, Chang SE, Choi JH, Lee MW. Clinical evaluation of 30 patients with localized nasal rosacea. J Dermatol. 2016;43:200–2.CrossRef
19.
go back to reference Solé-Boldo L, Raddatz G, Schütz S, et al. Single-cell transcriptomes of the human skin reveal age-related loss of fibroblast priming. Commun Biol. 2020;3:188.CrossRef Solé-Boldo L, Raddatz G, Schütz S, et al. Single-cell transcriptomes of the human skin reveal age-related loss of fibroblast priming. Commun Biol. 2020;3:188.CrossRef
20.
go back to reference Zuo Z, Wang B, Shen M, et al. Skincare habits and rosacea in 3,439 Chinese adolescents: a university-based cross-sectional study. Acta Derm Venereol. 2020;100: adv00081.CrossRef Zuo Z, Wang B, Shen M, et al. Skincare habits and rosacea in 3,439 Chinese adolescents: a university-based cross-sectional study. Acta Derm Venereol. 2020;100: adv00081.CrossRef
21.
go back to reference Li J, Wang B, Deng Y, et al. Epidemiological features of rosacea in Changsha, China: a population-based, cross-sectional study. J Dermatol. 2020;47:497–502.CrossRef Li J, Wang B, Deng Y, et al. Epidemiological features of rosacea in Changsha, China: a population-based, cross-sectional study. J Dermatol. 2020;47:497–502.CrossRef
22.
go back to reference Zouboulis CC, Chen WC, Thornton MJ, Qin K, Rosenfield R. Sexual hormones in human skin. Hormone and metabolic research Hormon- und Stoffwechselforschung Hormones et metabolisme. 2007;39:85–95.CrossRef Zouboulis CC, Chen WC, Thornton MJ, Qin K, Rosenfield R. Sexual hormones in human skin. Hormone and metabolic research Hormon- und Stoffwechselforschung Hormones et metabolisme. 2007;39:85–95.CrossRef
23.
go back to reference Del Rosso JQ. Advances in understanding and managing rosacea: part 1: connecting the dots between pathophysiological mechanisms and common clinical features of rosacea with emphasis on vascular changes and facial erythema. J Clin Aesthet Dermatol. 2012;5:16–25.PubMedPubMedCentral Del Rosso JQ. Advances in understanding and managing rosacea: part 1: connecting the dots between pathophysiological mechanisms and common clinical features of rosacea with emphasis on vascular changes and facial erythema. J Clin Aesthet Dermatol. 2012;5:16–25.PubMedPubMedCentral
24.
go back to reference Hirt PA, Castillo DE, Yosipovitch G, Keri JE. Skin changes in the obese patient. J Am Acad Dermatol. 2019;81:1037–57.CrossRef Hirt PA, Castillo DE, Yosipovitch G, Keri JE. Skin changes in the obese patient. J Am Acad Dermatol. 2019;81:1037–57.CrossRef
25.
go back to reference Seo YJ, Li ZJ, Choi DK, et al. Regional difference in sebum production by androgen susceptibility in human facial skin. Exp Dermatol. 2014;23:70–2.CrossRef Seo YJ, Li ZJ, Choi DK, et al. Regional difference in sebum production by androgen susceptibility in human facial skin. Exp Dermatol. 2014;23:70–2.CrossRef
26.
go back to reference Smith KE, Fenske NA. Cutaneous manifestations of alcohol abuse. J Am Acad Dermatol. 2000;43:1–16 (Quiz -8).CrossRef Smith KE, Fenske NA. Cutaneous manifestations of alcohol abuse. J Am Acad Dermatol. 2000;43:1–16 (Quiz -8).CrossRef
27.
go back to reference Higgins E, du Vivier A. Alcohol intake and other skin disorders. Clin Dermatol. 1999;17:437–41.CrossRef Higgins E, du Vivier A. Alcohol intake and other skin disorders. Clin Dermatol. 1999;17:437–41.CrossRef
28.
go back to reference Li S, Cho E, Drucker AM, Qureshi AA, Li WQ. Alcohol intake and risk of rosacea in US women. J Am Acad Dermatol. 2017;76:1061-7.e2.CrossRef Li S, Cho E, Drucker AM, Qureshi AA, Li WQ. Alcohol intake and risk of rosacea in US women. J Am Acad Dermatol. 2017;76:1061-7.e2.CrossRef
29.
go back to reference Curnier A, Choudhary S. Rhinophyma: dispelling the myths. Plast Reconstr Surg. 2004;114:351–4.CrossRef Curnier A, Choudhary S. Rhinophyma: dispelling the myths. Plast Reconstr Surg. 2004;114:351–4.CrossRef
Metadata
Title
Clinical Features and Risk Factors for Nasal Rosacea: A Hospital-Based Retrospective Study
Authors
Ai-ke Wu
Fang-fen Liu
Hong-fu Xie
Zhi-xiang Zhao
Yan Tang
Ying-xue Huang
Dan Jian
Wei Shi
Ben Wang
Ji Li
Publication date
01-12-2021
Publisher
Springer Healthcare
Keywords
Erythema
Rosacea
Published in
Dermatology and Therapy / Issue 6/2021
Print ISSN: 2193-8210
Electronic ISSN: 2190-9172
DOI
https://doi.org/10.1007/s13555-021-00605-w

Other articles of this Issue 6/2021

Dermatology and Therapy 6/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine